Latest California Healthline Stories
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Sarah Kliff of Vox and Alice Ollstein of Talking Points Memo discuss a proposed administration regulation that seeks to separate Planned Parenthood from federal family planning funds, the final congressional passage of legislation aimed at helping those with terminal illnesses obtain experimental medications, and new government reports on the uninsured and federal health spending. Also, Rovner interviews KHN’s Liz Szabo about the May “Bill of the Month.”
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trump’s proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
In a case with possible national repercussions, the state’s attorney general has sued over alleged price gouging, and other legal and legislative challenges are afoot. Sutter is pushing back hard, denying anticompetitive behavior.
A judge orders the county to fix problem that harmed low-income seniors and people with disabilities, including those with serious health conditions.
A lawsuit claims that a private company hired by the state public health department to manage enrollment in an AIDS drug assistance program for low-income patients inadvertently allowed unauthorized access to their medical status.
In a bold move, the state has sued Sutter Health, Northern California’s dominant hospital chain, whose prices have drawn complaints for years. The company says “healthy competition and choice exists across Northern California” for consumers seeking medical care.
In September, the Trump administration announced its plan to end the Deferred Action for Childhood Arrivals program, setting off an ongoing political and legal battle that could doom the dreams of immigrant doctors in training.
Purdue Pharma, whose signature product helped fuel the opioid epidemic, now wants to help treat it — or at least salvage its own reputation.
Three participants in unauthorized herpes vaccine research file a lawsuit against scientist’s company, alleging adverse side effects.
California officials should have obtained federal approval before they cut reimbursement rates for dental hygienists who serve frail Californians living in nursing homes and board-and-care facilities, a judge has ruled.